Shoulder Innovations, an emerging leader in orthopedics and the broader medtech industry, recently announced the launch of its newest product – the InSet™ 95 Humeral Stem. This cutting-edge solution is designed to enhance surgical outcomes for those undergoing shoulder replacement but suffering from relatively poorer bone quality. The InSet™ technology, now available to surgeons across the US, is fully integrated with the company’s comprehensive implant system.

Analyst Insights: Transforming Surgery in the Growing Shoulder Replacement Market 

Building on the company’s suite of solutions, the InSet™ 95 Humeral Stem fills a gap for surgeons managing patients with poorer humeral bone quality, expanding their offering to better serve a breadth of patients undergoing anatomic and reverse shoulder arthroplasty. The new technology not only enhances the longevity of the implant but also facilitates more reliable fixation, potentially reducing intraoperative complications and recovery times for patients.

Medtech companies building in the shoulder replacement market are poised for substantial growth. Insights from LSI’s Global Procedure Volumes Database shows that in the United States alone, approximately 61,000 shoulder replacement procedures were performed in 2023. This number is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030. On a global scale, approximately 426,600 shoulder replacement procedures were carried out in 2023, highlighting the widespread need for advanced solutions in this field.

The future of medtech and orthopedics is particularly bright with companies like Shoulder Innovations that are at the forefront of developing next-generation implant systems. As the demand for shoulder replacement increases, so does the need for innovative products that can deliver better patient outcomes and streamlined surgical processes for previously underserved areas of the market, such as for patients with relatively poorer humeral bone quality. The capability to enable more efficient conversion to a Reverse Shoulder Arthroplasty (RSA) is also expected to be a key value driver for this technology.

More on Shoulder Innovations

Shoulder Innovations has been one of the leading medtech companies selected to present at previous LSI events. Early in the company’s journey, their key executives presented at LSI USA ‘20 where they formed a relationship with USVP and, as a direct result, closed a $21.5M financing round (led by USVP). 

Most recently, Shoulder Innovations presented at LSI USA ‘24 – the flagship LSI emerging medtech summit, which convened hundreds of leading medtech companies, venture capital investors, global strategics, and more. The company’s presentations at LSI events can be found at the links below, alongside a deep library of proprietary company pitches, panels, interviews and more:

• Robert Ball, Shoulder Innovations - Innovative Solutions for Shoulder Arthroplasty | LSI USA '24

• Dave Blue, CCO, Shoulder Innovations | LSI USA '22

For more information on Shoulder Innovations, a full company profile is accessible in LSI’s Companies & Deals database, which provides coverage of over 6,000 medtech companies with associated deals, proprietary presentations and documents, and more. Learn more about LSI’s Companies & Deals database and full suite of market intelligence solutions for the medtech industry on our website.